NOD2 promotes coxsackievirus entry and pathogenesis
NOD2促进柯萨奇病毒进入和发病机制
基本信息
- 批准号:10285845
- 负责人:
- 金额:$ 23.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-18 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAffectAntiviral AgentsAreaBindingCell Culture TechniquesCell LineageCell membraneCellsCentral Nervous System DiseasesCoxsackie VirusesCoxsackievirus InfectionsCrohn&aposs diseaseCytomegalovirusCytoskeletonCytosolDataDevelopmentDiseaseDynaminEndocytosisEndoplasmic ReticulumEndosomesEnteralEnterovirusEnterovirus 71Epithelial CellsFamily PicornaviridaeFecesFoundationsFutureGastrointestinal tract structureHeartHumanHuman poliovirusImmunologic ReceptorsIn VitroInfectionInflammatory Bowel DiseasesInflammatory ResponseInfluenza A virusInsulin-Dependent Diabetes MellitusInterferon-alphaIntestinesKnock-outKnowledgeLeadMediatingMedicalMembraneMembrane ProteinsMitogen-Activated Protein KinasesModelingMusMycosesMyelogenousMyocarditisNuclearNucleotidesOralOrganPancreasParasitic infectionPathogenesisPathway interactionsPattern recognition receptorPeptidoglycanPhosphotransferasesProteinsPublishingRIPK2 geneReportingResearchResistanceRespiratory syncytial virusRhinovirusRoleRouteSignal PathwaySignal TransductionSiteSurfaceTestingTherapeutic InterventionTissuesVesicular stomatitis Indiana virusViralVirulenceVirusVirus DiseasesVirus ReceptorsVirus ReplicationWorkadenovirus receptorcommensal microbesendoplasmic reticulum stressenteric pathogenexperimental studygastrointestinal infectionin vivointestinal epitheliumintraperitonealloss of function mutationmouse modelnovelnucleotide receptororal infectionpathogenprotein functionreceptorrecruitrho GTP-Binding Proteinstherapeutic developmentuptake
项目摘要
Project Summary
NOD2 is a cytosolic pattern recognition receptor that senses and responds to bacterial peptidoglycan,
activated small Rho GTPases, endoplasmic reticulum stress and viral, fungal and parasitic infections. NOD2 is
localized in the cytosol, and upon activation, associates with the plasma membrane and endosomes, which is
essential for NOD2 function. Activation of NOD2 results in recruitment of RIPK2 leading to a pro-inflammatory
response dependent on NF-B and MAPK signaling pathways. NOD2 restriction of bacterial invasion at the
intestinal epithelial surface has been strongly implicated in inflammatory bowel diseases such as Crohn's
disease (CD) as loss-of-function mutations in Nod2 can promote the development and onset of CD. Moreover,
NOD2 is broadly antiviral as it restricts cytomegalovirus, respiratory syncytial virus, vesicular stomatitis virus
and influenza A virus infections. Paradoxically, NOD2 promoted coxsackievirus B3 (CVB3) infection in mice.
We found that NOD2 and RIPK2 enhance CVB3 entry in vitro, and NOD2 increases CVB3 pathogenesis in
vivo. The following are unknown regarding the impact of NOD2 on CVB3 infection: (1) the mechanism
underlying the requirement of NOD2 for efficient CVB3 replication, (2) the novel function for NOD2 during
CVB3 entry and (3) the effect of NOD2 on CVB3 infection in the gastrointestinal tract, the initial and natural site
of infection. We hypothesize that CVB3 has evolved to usurp NOD2 for optimal viral replication in the
gastrointestinal tract to promote CVB3 dissemination to other organs, which causes increased CVB3-
induced pathogenesis. We will test our hypothesis by pursuing two aims. For Aim 1, we will use in vitro cell
culture infection models in intestinal epithelial cells (IEC) to determine the mechanism for NOD2 enhancement
of CVB3 entry into cells. We will investigate whether NOD2 impacts CVB3 binding to its receptor (CAR), if
NOD2 is recruited to sites of CVB3 entry and whether membrane localization is required for CVB3 to enter
cells. We will also assess whether NOD2 affects CVB3 uptake by influencing the cell cytoskeleton. Aim 2 will
examine the in vivo contribution of NOD2 on CVB3 infection. We will identify what cell lineage is critical for the
impact of NOD2 on CVB3 infection and pathogenesis in a mouse model. As CVB3 is a fecal-oral transmitted
virus that infects the intestine prior to spreading to other organs, we will use an oral infection model in our
Nod2-sufficient and -deficient mice, using an Interferon alpha/beta receptor knock-out (Ifnar1-/-) background to
render mice more orally susceptible, to ascertain the importance of NOD2 during intestinal CVB3 infection.
Altogether, these studies will define how CVB3 exploits the innate immune receptor NOD2. Information from
the proposed research could lead to the development of therapeutics for coxsackievirus infections and possibly
other enteroviruses, will help us understand host intestinal influences on CVB3 and will propel future studies
focused on other viral infections.
项目摘要
NOD 2是一种细胞溶质模式识别受体,可感知并响应细菌肽聚糖,
活化的小Rho GTP酶、内质网应激和病毒、真菌和寄生虫感染。NOD 2是
定位于胞质溶胶中,并且在活化时,与质膜和内体缔合,
NOD 2的功能。NOD 2的激活导致RIPK 2的募集,导致促炎性细胞因子的产生。
反应依赖于NF-κ B B和MAPK信号通路。NOD 2限制细菌侵入
肠上皮表面与炎症性肠病如克罗恩病密切相关
Nod 2的功能缺失突变可促进CD的发展和发作。此外,委员会认为,
NOD 2是广泛的抗病毒,因为它限制巨细胞病毒,呼吸道合胞病毒,水泡性口炎病毒,
和甲型流感病毒感染。NOD 2可促进小鼠柯萨奇病毒B3(CVB 3)感染。
我们发现NOD 2和RIPK 2在体外增强了CVB 3的进入,并且NOD 2在体外增加了CVB 3的致病性。
vivo.关于NOD 2对CVB 3感染的影响,以下是未知的:(1)机制
NOD 2对CVB 3有效复制的潜在需求,(2)NOD 2在CVB 3复制过程中的新功能,
NOD 2对CVB 3在胃肠道中感染的影响,即初始和自然部位
感染我们假设,CVB 3已经进化到取代NOD 2,以实现最佳的病毒复制。
胃肠道促进CVB 3传播到其他器官,这导致CVB 3-
诱发发病机制。我们将通过追求两个目标来检验我们的假设。对于目标1,我们将使用体外细胞
在肠上皮细胞(IEC)中培养感染模型以确定NOD 2增强的机制
CVB 3进入细胞。我们将研究NOD 2是否影响CVB 3与其受体(CAR)的结合,如果
NOD 2被募集到CVB 3进入的位点,以及CVB 3进入是否需要膜定位
细胞我们还将评估NOD 2是否通过影响细胞骨架来影响CVB 3摄取。目标2将
检测NOD 2对CVB 3感染的体内作用。我们将确定什么样的细胞谱系对于
小鼠模型中NOD 2对CVB 3感染和发病机制的影响。由于CVB 3是一种粪-口传播的病毒,
在传播到其他器官之前感染肠道的病毒,我们将在我们的研究中使用口腔感染模型。
使用干扰素α/β受体敲除(Ifnar 1-/-)背景,
使小鼠更加口服敏感,以确定NOD 2在肠道CVB 3感染期间的重要性。
总之,这些研究将确定CVB 3如何利用先天免疫受体NOD 2。信息从
这项拟议中的研究可能会导致柯萨奇病毒感染的治疗方法的发展,
其他肠道病毒,将有助于我们了解宿主肠道对CVB 3的影响,并将推动未来的研究
专注于其他病毒感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arina Marijke Keestra-Gounder其他文献
Arina Marijke Keestra-Gounder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arina Marijke Keestra-Gounder', 18)}}的其他基金
The impact of ER stress on Salmonella Typhimurium infections
内质网应激对鼠伤寒沙门氏菌感染的影响
- 批准号:
10708073 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
The impact of ER stress on Salmonella Typhimurium infections
内质网应激对鼠伤寒沙门氏菌感染的影响
- 批准号:
10565316 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
NOD2 promotes coxsackievirus entry and pathogenesis
NOD2促进柯萨奇病毒进入和发病机制
- 批准号:
10407068 - 财政年份:2021
- 资助金额:
$ 23.33万 - 项目类别:
Activation of the NOD1 and NOD2 signaling pathways
NOD1 和 NOD2 信号通路的激活
- 批准号:
10041261 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Activation of the NOD1 and NOD2 signaling pathways
NOD1 和 NOD2 信号通路的激活
- 批准号:
10172844 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Targeting ER Stress in Inflammatory Bowel Disease
针对炎症性肠病的内质网应激
- 批准号:
9019324 - 财政年份:2016
- 资助金额:
$ 23.33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant